Analyst Research

Report Title Price
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Finlabo SIM Spa
$10.00
Provider: S&P Capital IQ – STARS Reports
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Sanofi SA Announces Reorganization of Research Activities in France


Friday, 17 May 2013 06:02am EDT 

Sanofi SA announced that it has confirmed its intent to regroup its research activities in France in the regions of Paris and Lyon, in Strasbourg and to transform the Montpellier R&D site into a strategic development center for the Company. The Company also intends to transform the structures of the site in Toulouse, so that it keeps a scientific and technological mission, and to safeguard a maximum number of jobs in the region. Based on the options considered in a report, Sanofi will explore the following: the creation of a technological platform to provide services for Sanofi and other biotechnological or pharmaceutical companies; the spin-off of activities dedicated to the development of innovative therapeutic solutions; and the establishment of local start-ups on the site. In addition, as already announced, the anti-infectious research of the site will be moved to Lyon. 

Company Quote

73.66
1.75 +2.43%
31 Oct 2014